1. Buisseret L., Garauda S., de Windc A., et al.
Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.
Oncoimmunology 2017;  6: e1257452. doi: 10.1080/2162402X.2016.1257452

2. Darb-Esfahani S., Kolaschinski I., Trillsch F., et al.
Morphology and tumor-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival.
Histopathology 2018 Jul 14. doi: 10.1111/his.13711. [Epub ahead of print]

3. Emile J.F., Julié C., Le Malicot K., et al.
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX.
Eur J Cancer 2017; 82:16-24

​4. Eriksen A.C., Sørensen F.B., Lindebjerg J., et al.
The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study.
Transl Oncol 2018 Aug;11(4):979-987. doi: 10.1016/j.tranon.2018.03.008. Epub 2018 Jun 22.

​5. Eryilmaz M.K., Mutlu H., Ünal B., et al.
The importance of stromal and intratumoral tumor lymphocyte infiltration for pathologic complete response in patients with locally advanced breast cancer.
J Cancer Res Ther 2018 Apr-Jun;14(3):619-624. doi: 10.4103/0973-1482.174550.

6. Fang W., Chen Y., Sheng J., et al.
Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer.
J Cancer 2017; 8:1579-1585

7. Gomez-Brouchet A., Illac C., Gilhodes J., et al.
CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial.
Oncoimmunology 2017; 6:e1331193. doi: 10.1080/2162402X.2017.1331193. eCollection 2017.
8. Granetto C., Ricci V., Fea E., et al.
Correlation between the prognostic value of tumor-infiltrating lymphocytes (TILS) and sidedness in colorectal cancer (CC) patients (pts).
Ann Oncol 2017; 28, Issue suppl_3, 1 June 2017, mdx261.267

9. Igari F., Sato E., Horimoto Y., et al.
Diagnostic Significance of Intratumoral CD8+ Tumor Infiltrating Lymphocytes in Medullary Carcinoma.
Hum Pathol 2017 Nov 6. pii: S0046-8177(17)30389-1. doi: 10.1016/j.humpath.2017.10.020. [Epub ahead of print]
10. Jesinghaus M., Steiger K., Slotta-Huspenina J., et al.
Increased intraepithelial CD3+ T-lymphocytes and high PDL1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
Oncotarget 2017; 8:46756-46768
11. Kashiwagi S., Asano Y., Goto W., et al.
Using TILs to Predict Therapeutic Effect of Chemotherapy (Pertuzumab, Trastuzumab, Docetaxel) on HER2-positive Breast Cancer.
Anticancer Res 2017; 37:5623-5630

12. Kim J.Y., Kim C.H., Lee Y., et al.
Tumour infiltrating lymphocytes are predictors of lymph node metastasis in early gastric cancers.
Pathology 2017; pii: S0031-3025(17)30226-X
​13. Khoury T., Peng X., Yan L., et al.
Tumor-Infiltrating Lymphocytes in Breast Cancer: Evaluating Interobserver Variability, Heterogeneity, and Fidelity of Scoring Core Biopsies.
Am J Clin Pathol 2018 Jul 25. doi: 10.1093/ajcp/aqy069. [Epub ahead of print]

14. Leon-Ferre R.A,, Polley M.Y. , Liu H., et al.
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.
Breast Cancer Res Treat 2017 Sep 14. doi: 10.1007/s10549-017-4499-7.

15. Liu S., Chen B., Burugu S., et al.
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer. A Secondary Analysis of a Randomized Clinical Trial.
JAMA Oncol 2017; Published online July 27. doi:10.1001/jamaoncol.2017.2085


16. Lo Nigro C., Comino A., Vivenza D., et al.
Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer.
Annals of Oncology, Volume 27, Issue suppl_6, 1 October 2016

17. Merlano M., Ricci V., Garrone O., et al.
T memory cells in the tumor invasive margins affect survival in colon cancer (CC) but not in breast cancer (BC).
Journal of Clinical Oncology 2016 34:15_suppl, e23104-e23104

18. Miligy I., Mohan P., Gaber A., et al.
Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.
Histopathology 2017; 71:258-268

19. Nejati R., Goldstein J.B., Halperin D.M., et al.
Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy.
Pancreas 2017; 46:1180-1187
​20. Rakaee M., Kilvaer T.K., Dalen S.M., et al.
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.
Hum Pathol 2018 Jun 6. pii: S0046-8177(18)30185-0. doi: 10.1016/j.humpath.2018.05.017. [Epub ahead of print]

21. Sideras K., Galjart B., Vasaturo A., et al.
Prognostic value of intra-tumoral CD8+ /FoxP3+ lymphocyte ratio in patients with resected colorectal cancer liver metastasis.
J Surg Oncol 2018 Jun 7. doi: 10.1002/jso.25091. [Epub ahead of print]

22. Solinas C., Carbognin L., De Silva P., et al.
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art.
Breast 2017; 35:142-150
23. Tas F. and Erturk K.
Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients.
Cancer Invest 2017 Aug 11:1-5. doi: 10.1080/07357907.2017.1351984

​24. Urru S.A.M., Gallus S., Bosetti C., et al.
Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
BMC Cancer 2018 Jan 8;18(1):56. doi: 10.1186/s12885-017-3969-y.

25. Versluis M.A.C., Marchal S., Plat A., et al.
The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment.
Eur J Cancer 2017 20;86:285-295

26. Vycital O., Dubova M., Palek R., et al.
The Impact of Immune Interaction on the Metastatic Infiltration of Colorectal Carcinoma to Lymph Nodes.
Anticancer Res 2018 Jul;38(7):4159-4167. doi: 10.21873/anticanres.12709.

​27. Wang H., Li Z., Dong B., et al.
Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.
Diagn Pathol 2018 May 22;13(1):30. doi: 10.1186/s13000-018-0712-1.

28. Wang K., Shen T., Siegal G.P., et al.
The CD4/CD8 Ratio of Tumor-infiltrating Lymphocytes at the Tumor-host Interface Has Prognostic Value in Triple Negative Breast Cancer.
Hum Pathol 2017 Oct 6. pii: S0046-8177(17)30357-X. doi: 10.1016/j.humpath.2017.09.012. [Epub ahead of print]
29. Wein L., Savas P., Luen S.J., et al.
Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions.
Front Oncol 2017 Aug 3;7:156. doi: 10.3389/fonc.2017.00156. eCollection 2017.

​30. Zhang L., Wang X.I., Zhang S.
Tumor infiltrating lymphocyte volume is a better predictor of neoadjuvant therapy response and overall survival in triple negative invasive breast Cancer.
Hum Pathol 2018 Jun 5. pii: S0046-8177(18)30192-8. doi: 10.1016/j.humpath.2018.05.024. [Epub ahead of print]

31. Zhang S., Wang J., Zhang X., et al.
Tumor-infiltrating CD8+ lymphocytes predict different clinical outcomes in organ- and non-organ-confined urothelial carcinoma of the bladder following radical cystectomy.
PeerJ 2017 Oct 13;5:e3921. doi: 10.7717/peerj.3921. eCollection 2017.